Literature DB >> 10407776

Glutaric aciduria type I: pathomechanisms of neurodegeneration.

K Ullrich1, B Flott-Rahmel, P Schluff, U Musshoff, A Das, T Lücke, R Steinfeld, E Christensen, C Jakobs, A Ludolph, A Neu, R Röper.   

Abstract

In organotypic corticostriatal and hippocampal slice cultures from rat brain, 3-hydroxyglutaric acid but not glutaric and glutaconic acids induced neurodegeneration by activation of NMDA receptors. Electrophysiological investigations (Xenopus laevis oocytes expressing glutamate receptors; rat mixed cortex culture) revealed no direct interaction of 3-hydroxyglutaric acid with glutamate receptors. We speculate that 3-hydroxyglutaric acid induces a mild energy deprivation that interferes with the voltage-dependent Mg(2+)-block of NMDA receptors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10407776     DOI: 10.1023/a:1005595921323

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  38 in total

1.  Developmental and regional expression in the rat brain and functional properties of four NMDA receptors.

Authors:  H Monyer; N Burnashev; D J Laurie; B Sakmann; P H Seeburg
Journal:  Neuron       Date:  1994-03       Impact factor: 17.173

2.  Neurotoxicity at the N-methyl-D-aspartate receptor in energy-compromised neurons. An hypothesis for cell death in aging and disease.

Authors:  R C Henneberry; A Novelli; J A Cox; P G Lysko
Journal:  Ann N Y Acad Sci       Date:  1989       Impact factor: 5.691

3.  Prenatal diagnosis of inherited metabolic disorders by stable isotope dilution GC-MS analysis of metabolites in amniotic fluid: review of four years experience.

Authors:  C Jakobs
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

4.  Hypothesis: a role for quinolinic acid in the neuropathology of glutaric aciduria type I.

Authors:  M P Heyes
Journal:  Can J Neurol Sci       Date:  1987-08       Impact factor: 2.104

5.  The inhibition of mouse brain glutamate decarboxylase by some structural analogues of L-glutamic acid.

Authors:  P V Taberner; M J Pearce; J C Watkins
Journal:  Biochem Pharmacol       Date:  1977-02-15       Impact factor: 5.858

Review 6.  Striatal degeneration and spongy myelinopathy in glutaric acidemia.

Authors:  D Soffer; N Amir; O N Elpeleg; J M Gomori; R S Shalev; S Gottschalk-Sabag
Journal:  J Neurol Sci       Date:  1992-02       Impact factor: 3.181

Review 7.  Glutamate in neurologic diseases.

Authors:  P Bittigau; C Ikonomidou
Journal:  J Child Neurol       Date:  1997-11       Impact factor: 1.987

8.  Glutamate and gamma-aminobutyric acid neurotransmitter systems in the acute phase of maple syrup urine disease and citrullinemia encephalopathies in newborn calves.

Authors:  P R Dodd; S H Williams; A L Gundlach; P A Harper; P J Healy; J A Dennis; G A Johnston
Journal:  J Neurochem       Date:  1992-08       Impact factor: 5.372

Review 9.  Some chemical highlights in the development of excitatory amino acid pharmacology.

Authors:  J C Watkins
Journal:  Can J Physiol Pharmacol       Date:  1991-07       Impact factor: 2.273

10.  Evidence that the loss of the voltage-dependent Mg2+ block at the N-methyl-D-aspartate receptor underlies receptor activation during inhibition of neuronal metabolism.

Authors:  G D Zeevalk; W J Nicklas
Journal:  J Neurochem       Date:  1992-10       Impact factor: 5.372

View more
  33 in total

1.  Inhibition of energy production in vitro by glutaric acid in cerebral cortex of young rats.

Authors:  C G Silva; A R Silva; C Ruschel; C Helegda; A T Wyse; C M Wannmacher; C S Dutra-Filho; M Wajner
Journal:  Metab Brain Dis       Date:  2000-06       Impact factor: 3.584

Review 2.  Glutaric aciduria type 1 and neonatal screening: time to proceed--with caution.

Authors:  Andrea Superti-Furga
Journal:  Eur J Pediatr       Date:  2003-10-25       Impact factor: 3.183

3.  Geometric restraint drives on- and off-pathway catalysis by the Escherichia coli menaquinol:fumarate reductase.

Authors:  Thomas M Tomasiak; Tara L Archuleta; Juni Andréll; César Luna-Chávez; Tyler A Davis; Maruf Sarwar; Amy J Ham; W Hayes McDonald; Victoria Yankovskaya; Harry A Stern; Jeffrey N Johnston; Elena Maklashina; Gary Cecchini; Tina M Iverson
Journal:  J Biol Chem       Date:  2010-11-23       Impact factor: 5.157

4.  Infant mice with glutaric acidaemia type I have increased vulnerability to 3-nitropropionic acid toxicity.

Authors:  K B Bjugstad; L S Crnic; S I Goodman; C R Freed
Journal:  J Inherit Metab Dis       Date:  2006-08-30       Impact factor: 4.982

Review 5.  Challenges for basic research in glutaryl-CoA dehydrogenase deficiency.

Authors:  S Kölker; K A Strauss; S I Goodman; G F Hoffmann; J G Okun; D M Koeller
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

6.  Energy metabolism is compromised in skeletal muscle of rats chronically-treated with glutaric acid.

Authors:  Gustavo da C Ferreira; Patrícia F Schuck; Carolina M Viegas; Anelise Tonin; Alexandra Latini; Carlos S Dutra-Filho; Angela T S Wyse; Clóvis M D Wannmacher; Carmen R Vargas; Moacir Wajner
Journal:  Metab Brain Dis       Date:  2007-01-13       Impact factor: 3.584

7.  Glutaric acid administration impairs energy metabolism in midbrain and skeletal muscle of young rats.

Authors:  Gustavo da C Ferreira; Carolina M Viegas; Patrícia F Schuck; Anelise Tonin; César A J Ribeiro; Daniella de M Coelho; Teresa Dalla-Costa; Alexandra Latini; Angela T S Wyse; Clovis M D Wannmacher; Carmen R Vargas; Moacir Wajner
Journal:  Neurochem Res       Date:  2005-09       Impact factor: 3.996

Review 8.  Structural basis for malfunction in complex II.

Authors:  Tina M Iverson; Elena Maklashina; Gary Cecchini
Journal:  J Biol Chem       Date:  2012-08-17       Impact factor: 5.157

9.  Biochemistry and bioenergetics of glutaryl-CoA dehydrogenase deficiency.

Authors:  S W Sauer
Journal:  J Inherit Metab Dis       Date:  2007-09-21       Impact factor: 4.982

10.  Profiling of oxidative stress in patients with inborn errors of metabolism.

Authors:  Peter J Mc Guire; Aditya Parikh; George A Diaz
Journal:  Mol Genet Metab       Date:  2009-06-14       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.